Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Research applications The combined study of BPC-157 and TB-500 is primarily relevant for research questions where cell recruitment, migration, and coordinated remodeling are limiting factors
Protocols that already use Wolverine (BPC-157 + TB-500) and want to add a tissue-quality layer
In terms of mechanisms, NAD+ supports DNA repair by activating enzymes known as sirtuins, which help maintain genomic stability
Study Design Type: Phase 2, double-blind, randomized, placebo-controlled study Participants: 338 adults (BMI 30 or BMI 27 with a coexisting condition) Groups: Retatrutide 1 mg, 4 mg, 8 mg, 12 mg (different initial doses 2 or 4 mg) and placebo Duration: 48 weeks (plus 4 weeks follow-up) Administration: subcutaneous, 1x weekly Primary endpoint: percentage change in body weight at week 24 Secondary endpoints: change in weight at week 48, 5%, 10%, 15% weight reduction
Please contact: Where to buy BPC-157
Cochrane Database Syst
